𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Optimal scan time for evaluating pancreatic disease with positron emission tomography using F-18-fluorodeoxyglucose

✍ Scribed by Yuji Nakamoto; Tsuneo Saga; Tatsuya Higashi; Takayoshi Ishimori; Hisataka Kobayashi; Koichi Ishizu; Noriko Sato; Marcelo Mamede; Harumi Sakahara; Masayuki Imamura; Junji Konishi

Publisher
Springer Japan
Year
2003
Tongue
English
Weight
750 KB
Volume
17
Category
Article
ISSN
0914-7187

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

18F-fluorodeoxyglucose–positron emission
18F-fluorodeoxyglucose–positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease
✍ Laurent Arnaud; Zoulikha Malek; Frédérique Archambaud; Aurélie Kas; Dan Toledano 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB 👁 2 views

## Abstract ## Objective Erdheim‐Chester disease (ECD) is a rare form of non–Langerhans' cell histiocytosis. The aim of this study was to assess the value of whole‐body scanning with ^18^F‐fluorodeoxyglucose–positron emission tomography (FDG‐PET) in a large cohort of ECD patients from a single cen

Evaluation of chemotherapy response in p
Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography
✍ Val J. Lowe; Frank R. Dunphy; Mark Varvares; Han Kim; Mark Wittry; Cherie H. Dun 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 2 views

## Background: [f-18]fluorodeoxyglucose (fdg)-positron emission tomography (pet) can measure the metabolic activity of tissues; fdg-pet may be able to predict response to chemotherapy by identifying changes in tumor metabolism. measurement of response to treatment may help improve survival in the m